AddLife AB (publ) (FRA:1AD1)

Market Cap	1.79B -5.2%
Revenue (ttm)	950.80M +0.8%
Net Income	54.01M +77.4%
EPS	0.44 +77.2%
Shares Out	n/a
PE Ratio	33.13
Forward PE	22.47
Dividend	0.14 (0.96%)
Ex-Dividend Date	May 7, 2026

Volume	n/a
Open	14.62
Previous Close	14.55
Day's Range	14.62 - 14.62
52-Week Range	12.24 - 19.01
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytical instruments, equipment, microscopes, consumables, and reagents, as w...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1906
• Employees: 2,360
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1AD1

Financial Performance

In 2025, AddLife AB's revenue was 10.44 billion, an increase of 1.52% compared to the previous year's 10.29 billion. Earnings were 560.00 million, an increase of 122.22%.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error